Volume 17, Issue 4 (Paramedical Sciences and Military Health (winter 2023) 2022)
Paramedical Sciences and Military Health 2022, 17(4): 61-71 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mousavi A S, Darroudi R, Abbaszadeh A, Dahmardeh F, Mousavi Baigi S F. The Effect of Telemedicine on The Recovery of Patients with Chronic Gastrointestinal Disease: A Systematic Review of Randomized Controlled Trials. Paramedical Sciences and Military Health 2022; 17 (4) :61-71
URL: http://jps.ajaums.ac.ir/article-1-334-en.html
URL: http://jps.ajaums.ac.ir/article-1-334-en.html
Atefeh Sadat Mousavi 
1, Reza Darroudi2 , Ali Abbaszadeh3 , Fatemeh Dahmardeh4 , Seyyedeh Fatemeh Mousavi Baigi4
1, Reza Darroudi2 , Ali Abbaszadeh3 , Fatemeh Dahmardeh4 , Seyyedeh Fatemeh Mousavi Baigi4
1- Department of Health Information Technology, School of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran , Mousaviat971@mums.ac.ir
2- Department of Health Information Technology, Neyshabur Mashhad University of Medical Sciences, Neyshabur, Iran
3- Student Research Committee, AJA University of Medical Science, Tehran, Iran
4- Department of Health Information Technology, School of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Health Information Technology, Neyshabur Mashhad University of Medical Sciences, Neyshabur, Iran
3- Student Research Committee, AJA University of Medical Science, Tehran, Iran
4- Department of Health Information Technology, School of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract: (555 Views)
Introduction: Gastrointestinal diseases are associated with significant healthcare costs and complications worldwide. The aim of this systematic review was to investigate the effect of telemedicine on improving symptoms, reducing disease burden, and improving quality of life (QoL) in patients with gastrointestinal diseases.
Methods and Materials: A systematic review of randomized controlled trial studies was explored by searching keywords in the title, abstract, and keywords of the studies in Embase, Web of Science, Scopus, and PubMed scientific databases between the years of 2012 and 2022. A gray literature search was also conducted using the Google search engine to identify the most recent possible evidence. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Clinical trialas or randomized controlled trials that used telemedicine or telehealth methods to improve QoL and disease activity in patients with gastrointestinal diseases and those articles whose full text was available in English were considered to meet the inclusion criteria.
Results: At first, 963 studies were extracted by searching the database. 870 articles were identified after removing duplicates. After screening the full text of the articles, nine studies met the inclusion criteria. The number of participants included 2092 people in the input studies. The duration of the intervention in
each study varied from 6 weeks to 12 months. The technologies used included a robot-based platform 33%, remote monitoring 44%, and a mobile-based application 22%. In 22% of the studies, telemedicine interventions improved the QoL, 33% of the studies showed a decrease in the number of outpatient visits
and hospital admissions, and 22% of the studies showed improvement in symptom management in patients. In addition, 11% of the studies showed cost-effectiveness and effectiveness, and 11% of the studies reported a reduction in the use of health care resources.
Discussion and Conclusion: The results of the present systematic review showed that in the majority of studies, telemedicine interventions had better results than traditional interventions; however, a telemedicine program can supplement or replace in-person medical visits to improve the QoL, it can reduce the burden of disease in patients with gastrointestinal diseases and it can improve the patient’s health.
Methods and Materials: A systematic review of randomized controlled trial studies was explored by searching keywords in the title, abstract, and keywords of the studies in Embase, Web of Science, Scopus, and PubMed scientific databases between the years of 2012 and 2022. A gray literature search was also conducted using the Google search engine to identify the most recent possible evidence. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Clinical trialas or randomized controlled trials that used telemedicine or telehealth methods to improve QoL and disease activity in patients with gastrointestinal diseases and those articles whose full text was available in English were considered to meet the inclusion criteria.
Results: At first, 963 studies were extracted by searching the database. 870 articles were identified after removing duplicates. After screening the full text of the articles, nine studies met the inclusion criteria. The number of participants included 2092 people in the input studies. The duration of the intervention in
each study varied from 6 weeks to 12 months. The technologies used included a robot-based platform 33%, remote monitoring 44%, and a mobile-based application 22%. In 22% of the studies, telemedicine interventions improved the QoL, 33% of the studies showed a decrease in the number of outpatient visits
and hospital admissions, and 22% of the studies showed improvement in symptom management in patients. In addition, 11% of the studies showed cost-effectiveness and effectiveness, and 11% of the studies reported a reduction in the use of health care resources.
Discussion and Conclusion: The results of the present systematic review showed that in the majority of studies, telemedicine interventions had better results than traditional interventions; however, a telemedicine program can supplement or replace in-person medical visits to improve the QoL, it can reduce the burden of disease in patients with gastrointestinal diseases and it can improve the patient’s health.
Keywords: Telemedicine, Chronic Gastrointestinal Disease, Improvement of Quality of Life, Mobile Health
Type of Study: review |
Subject:
full articles
Received: 2022/12/12 | Accepted: 2023/04/6 | Published: 2023/03/20
Received: 2022/12/12 | Accepted: 2023/04/6 | Published: 2023/03/20
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
